Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant fusion protein consisting of the extracellular portion of human activin receptor IIB linked to the human IgG1 Fc domain

EU orphan designation number: EU/3/10/812   
Active ingredient: Recombinant fusion protein consisting of the extracellular portion of human activin receptor IIB linked to the human IgG1 Fc domain
Indication: Treatment of Duchenne muscular dystrophy
Sponsor: Shire Pharmaceuticals Ireland Limited
5 River Walk, Citywest Business Campus, Dublin 24, Ireland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/12/2010 Centralised Orphan - Designation EMA/OD/085/10 (2010)8597 of 26/11/2010
18/05/2011 Centralised Orphan - Transfer of orphan designation EMEA/OD/085/10/T/01 (2011)3484 of 13/05/2011